J.W. Cole Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,692
Closed -$247K 866
2021
Q4
$247K Sell
2,692
-318
-11% -$38K 0.02% 719
2021
Q3
$382K Buy
3,010
+434
+17% +$63.2K 0.03% 302
2021
Q2
$428K Sell
2,576
-161
-6% -$26.1K 0.03% 475
2021
Q1
$497K Sell
2,737
-300
-10% -$69.6K 0.05% 391
2020
Q4
$607K Sell
3,037
-4,180
-58% -$850K 0.06% 302
2020
Q3
$1.58M Buy
+7,217
New +$1.53M 0.12% 182

Other funds holding TDOC

J.W. Cole Advisors's TDOC Position: Q1 2022 in Review

J.W. Cole Advisors sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 2,692 shares — an estimated $247K sold.

J.W. Cole Advisors first reported a position in TDOC in Q3 2020 and held it in 6 quarters. The position peaked at $1.58M in Q3 2020. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • J.W. Cole Advisors reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • J.W. Cole Advisors sold 2,692 Teladoc Health shares in Q1 2022, an estimated $247K.
  • J.W. Cole Advisors first reported a position in Teladoc Health in Q3 2020 and held it in 6 quarters.
  • J.W. Cole Advisors's Teladoc Health position peaked at $1.58M in Q3 2020.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on J.W. Cole Advisors's 13F filing for Q1 2022, filed 16 May 2022.